Phosphate-based glasses (PBGs) are ideal materials for regenerative medicine strategies because their composition, degradation rates, and ion release profiles can easily be controlled. Strontium has previously been found to simultaneously affect bone resorption and deposition. Therefore, by combining the inherent properties of resorbable PBG and therapeutic activity of strontium, these glasses could be used 
Phosphate-based glasses (PBGs) are highly suited biomaterials to deliver therapeutic ions, particularly for bone regeneration, because their main constituents (i.e., calcium, phosphate, sodium, and magnesium) are found to occur in the inorganic phase of natural bone (Jones & Clare, 2012) . The ability to control their dissolution rates, and thus the release of ions, serves as a highly attractive route to direct the biological response for the repair and regeneration of both hard and soft tissues (Hoppe, Guldal, & Boccaccini, 2011) . Furthermore, the geometry of PBG can be varied by means of fibre drawing (Ahmed, Collins, Lewis, Olsen, & Knowles, 2004; Sharmin, Rudd, Parsons, & Ahmed, 2016) , scaffold production (Jones et al., 2010) , and microsphere manufacture (Jones et al., 2010; Lakhkar et al., 2012) , making them an extremely versatile and tuneable material.
A particular ion of interest is strontium (Sr), especially for use in hard-tissue repair applications; it has been investigated for incorporation and/or substitution into a vast array of materials such as organic polymers, ceramics, glasses, composites, and alloys (Han et al., 2016; Liu, Li, Ji, & Jia, 2013; Mushahary et al., 2016; Park, Kang, & Hanawa, 2016; Ray et al., 2016; Schumacher & Gelinsky, 2015; Wu, Lin, Yang, & Lee, 2015) . Strontium is also of clinical importance because it has been shown to promote bone formation via stimulation of pre-osteoblastic cells replication and to reduce bone resorption via inhibition of osteoclast formation and activity (Canalis, Hott, Deloffre, Tsouderos, & Marie, 1996) . In the past, strontium ranelate was administrated to osteoporotic patients, due to its anabolic activity and antiresorptive effect on bone tissue (Ammann, 2005) , as the imbalance of bone deposition and resorption characterises osteoporosis (Blake & Fogelman, 2006) . However, since 2013, the European Medicine Agency has restricted the use of strontium ranelate for the treatment of severe osteoporosis in postmenopausal women and adult men at high risk of fracture due to increased cardiovascular risks (National Institute for Health and Care Excellence (NICE), 2011).
Therefore, investigation into alternative administration routes such as controlled and localised delivery of the ion, as opposed to systemic delivery, could be very beneficial.
Substitution of calcium for strontium in biomaterials (e.g., orthopaedic cements and bioactive glasses) has been of interest as both play a similar chemical role because they are divalent cations with a comparable ionic size (Ca 2+ 1.00 Å and Sr 2+ 1.18 Å) and are accumulated in bone. Due to the ease of substitution of these two cations within a glass system, as well as the positive influence strontium can have on bone metabolism, the use of this ion for bone tissue engineering and regenerative medicine strategies constitutes an area of growing interest (Abou Neel et al., 2009; Al Qaysi et al., 2015; Lee, Obata, Brauer, & Kasuga, 2015) . Several studies have investigated the behaviour of cells such as osteoblast-like cells and mesenchymal stem cells towards strontium-containing biomaterials (Aina et al., 2013; Lin et al., 2013; Ni, Shu, Huang, Lu, & Pan, 2012; SantocildesRomero et al., 2015) . For instance, Sr-substituted hydroxyapatite nanocrystals were shown to dose dependently promote higher levels of alkaline phosphatase (ALP) activity, collagen type-I, and osteocalcin production in comparison with pure hydroxyapatite in the osteoblastlike MG63 cell line (Capuccini et al., 2009) . Investigation into the effects of Sr-containing PBG has also been reported; for example, human osteosarcoma cells showed higher degree of adhesion to PBG with 1 and 3 mol% SrO substitution in comparison with the 5%
and SrO-free control (Abou Neel et al., 2009 ).
The aim of this study was to investigate the cytocompatibility of near invert phosphate glasses where calcium was eventually fully substituted for strontium on a gradual basis in a previously reported glass system 40P 2 O 5 ·(16-x)CaO·20Na 2 O·24MgO·xSrO (x = 0, 4, 8, 12, and 16 mol%; Patel et al., 2017) . All formulations were manufactured as discs and microspheres and tested for their ability to support adhesion, proliferation, and osteogenic differentiation using human osteoblast-like MG63 cells and human mesenchymal stem cells (hMSCs), respectively, in order to investigate their potential use for bone repair applications via two clinically relevant cell types.
| MATERIALS AND METHODS

| PBG sample production
The following precursors were used to fabricate glass rods of the compositions shown in placing the crucible into a furnace heated to 1150°C for 90 min. The melts were poured into preheated graphite moulds (10°C) above Tg of each sample and annealed for 1 hr, followed by slow cooling to room temperature overnight. Each rod was then cut into discs of 9 mm × 2 mm using a diamond saw using methanol as a lubricant agent. Sterilisation of the discs was carried out via UV light exposure for 1 hr on either side. was employed as control of conventional culture method.
For the experiments with the PBG microspheres, 2 × 10 4 GFPlabelled hMSCs (Harrison et al., 2017) were seeded onto 10-mg sterile microspheres in low-adherent 48-well plate previously coated with 1%
w/v solution of poly(2-hydroxyethyl methacrylate) (poly-HEMA, Sigma Aldrich) and ethanol 95%. Cells were cultured during 14 days at 37°C
and 5% CO 2 in standard cell (SC) culture medium (low glucose Dulbecco's Modified Eagle Media supplemented with 10% fetal calf serum, 1% penicillin and streptomycin, 1% L-glutamine, and 1% of non-essential amino acids). For both cell types, medium was refreshed every 48 hr.
| Cell metabolic activity
Cell metabolic activity of MG63 cells cultured on PBG discs and TCP was evaluated at Days 1, 3, 7, and 14 using Alamar Blue assay. Briefly, 1 ml of Alamar Blue solution (1:9 Alamar blue:Hanks Balanced Salt Solution) was added to each well and incubated for 90 min at 37°C and 5% CO 2 followed by further 10 min on a shaker at 150 rpm. For each disc, three aliquots of 100 μl were transferred to a 96-well plate.
FLx800 fluorescence microplate reader (BioTek Instruments Inc.) was used to measure fluorescence at 530-nm excitation and 590-nm emission wavelengths.
Cell metabolic activity of hMSCs was assayed using Presto Blue reagent at Days 2, 7, and 14 after seeding onto the microspheres according to the manufacturer's instructions. Briefly, a solution of SC medium supplemented with 10% of Presto Blue reagent was prepared, and 300 μl was added to the cells for 40 min at 37°C and 5% CO 2 .
After the incubation, 250 μl of the solution was transferred to a clear bottom 96-well plate; fluorescence measurement was performed in the microplate reader Infinite 200 (Tecan, CH) setting 560 nm and 590 nm as excitation and emission wavelengths, respectively.
| Evaluation of DNA content
DNA content was evaluated in MG63 cells at Days 1, 3, 7, and 14 of culture on PBG discs and TCP control. Briefly, samples were washed three times with warm (37°C) PBS and immersed in 1 ml of deionised water. Samples were frozen-thawed three times to lyse the cells and release nuclear content. Lysed samples were then thoroughly mixed using a vortex for 30-60 s, and 100 μl of each sample was aliquoted into a 96-well plate. Hoechst 33258 stain solution was prepared by dissolving 1 mg of bisbenzimide stain in 1 ml of distilled water and diluted 1:50 in TNE buffer (10 mM Tris, 2 M NaCl, and 1 mM EDTA in deionised water, adjusted to pH 7.4); DNA standard curve was prepared using calf thymus DNA (Sigma, UK) diluted in TNE buffer.
Each well was then topped with 100 μl of Hoechst 33258 stain and agitated using a plate shaker. Fluorescence was measured at 360 nm and 460 nm as excitation and emission wavelengths using FLx800 microplate fluorimeter (BioTek Instruments), respectively.
| ALP activity
The Granutest 25 ALP assay (Randox, UK) was used to measure ALP activity in MG63 cells. Three aliquots of 50 μl of cell lysate (as prepared for DNA quantification assay in Section 3.4) were transferred to a 96-well plate and topped with 50 μl of ALP substrate (p-nitrophenyl phosphate 10 mM in diethanolamine buffer 1 mM at pH 9.8, with
MgCl 2 0.5 mM). Plates were shaken gently for 5 min on a plate shaker, and absorbance was measured at wavelength of 405 nm using an FLx800 microplate colorimeter (BioTek Instruments). 3 | RESULTS
| Evaluation of MG63 cell growth on disc PBG formulations
In order to determine the cytocompatibility of glass samples with varying SrO content, the osteoblast-like MG63 cell line was seeded onto the surface of glass discs, and the cell metabolic activity as well as DNA quantity was analysed at Days 1, 3, 7, and 14. Metabolic activity analysed using the Alamar Blue assay showed an increase in cell response for all compositions from Day 3, whereas no significant differences were detected between formulations at all the time points considered (p > 0.9). At Days 3 and 7, significantly greater values were observed for the TCP control in comparison with all glasses, whereas at Day 14, this difference was maintained only in comparison with P40, Sr4, and Sr8 (see Figure 1a) .
Moreover, the quantification of total cell DNA amount showed a significant increase at each time point up to Day 7 (D1 vs. D3:
p < 0.01; D7 vs. D3: p < 0.0001), followed by a plateau at Day 14. It is worth noting that no significant differences were observed between all formulations and the TCP control at each time point (p > 0.9; see Figure 1b ).
| Evaluation of hMSC cell growth on microsphere PBG formulations
The metabolic activity of hMSCs cultured on microspheres manufactured from each PBG composition was assayed at Days 2, 7, and 14 after seeding. The results showed a significant increase in cell response over time (p < 0.0001), whereas no differences between cell cultures on the different PBG compositions were detected at each time point (p > 0.90; see Figure 2 ).
| ALP activity
ALP activity was measured as an early marker of osteogenic differentiation in MG63 and hMSCs after 14 days of culture on both PBG discs and microspheres, respectively. 
| hMSC cell imaging on microspheres
Live fluorescence images of hMSCs showed a similar level of cell adhesion to PBG microspheres across all formulations at Day 1, whereas the presence of cell-microsphere aggregates was observed at Day 14 (see Figure 5a ). These aggregates were further analysed via ESEM imaging, which showed the attachment and spreading of cells on the microsphere surface, as well as the presence of a dense cell-derived matrix surrounding the microspheres (see Figure 5b) . 
| DISCUSSION
This study aimed to assess the biological properties of a series of near invert PBGs where CaO content was gradually substituted for SrO by 0% to 100% (Patel et al., 2017) and manufactured in disc and microsphere forms. Microspheres in particular provide the advantage of uniformity in size and shape, making delivery to the target tissue possible through simple injection procedures (Kim & Pack, 2006) . Spherical material morphologies also enable enhanced versatility for filling even complex defect shapes compared with bulk scaffolds, which tend to have predetermined shapes (Choi, Zhang, Yeh, Wooten, & Xia, 2012) . The increased surface area also allows for efficient cell attachment and spreading, whereas the microsphere interparticulate gaps would be beneficial for oxygen and nutrient flow (Cai, Chen, Hong, Liu, & Yuan, 2013) . MG63 cells have been widely used as a versatile tool for the evaluation of the osteogenic potential of new materials and compounds (Rodriguez, Saxena, Hixon, Sell, & Bowlin, 2016) , whereas hMSCs cells have been included in this study as a clinically relevant cell model, largely used in in vitro and in vivo studies of bone regeneration (Knight & Hankenson, 2013) .
As previously demonstrated, the gradual replacement of CaO content for SrO by 0% to 100% in the glass system used in the this study influence of glass composition and degradation rate on cell behaviour was discussed by Skelton et al. (2007) who demonstrated the lack of attachment, proliferation, and increased cell death for human bone marrow stromal cells and human fetal osteoblasts cultured on ternary PBG systems. Such detrimental effects on cell behaviour were attributed to an unstable PBG surface in contact to cell culture medium, which led to a rapid dissolution of these fast degrading ternary formulations preventing cells from adhering to the surface.
In vivo too, the degradation rate of a material can significantly affect the outcome of the therapeutic strategy by either altering the structural support provided to the endogenous tissue and/or stimulating the inflammatory response (Vishwakarma et al., 2016; Yu, Tang, Gohil, & Laurencin, 2015) .
The dissolution behaviour of the PBG formulations studied here has been previously reported, showing a more stable PBG surface with the addition of SrO, with a weight loss ranging between 0.2% and 0.13% in 30 days for the discs (Patel et al., 2017) . Evidence also suggests that the degradation rate of the glass increases with spherical geometries (Hossain et al., 2018; Islam, Hossain, Sharmin, Parsons, & Ahmed, 2017) ; however, in vivo studies would need to The ability of a biomaterial to induce osteogenic differentiation is a desirable property in view of the application for bone repair. In this study, the assay of ALP activity was performed as an early marker of osteogenic commitment. This enzyme is constitutively active at low levels in all the cells, but its activity significantly increases during the early stages of osteogenic differentiation; therefore, it is commonly considered a good marker for the detection of early osteogenic differentiation (Golub & Boesze-Battaglia, 2007; Prins et al., 2014; Stein, Lian, & Owen, 1990) . Strontium ranelate, an Sr-based drug previously administrated to osteoporotic patients, has been reported to have a dual role by enhancing differentiation of osteogenic progenitor cells as well as by inhibiting osteoclastogenesis (Brennan et al., 2009; Fonseca & Brandi, 2010) . In this study, no significant difference in (Boanini et al., 2014) . It seems that such osteogenic effect exerted by strontium may be mediated by the activation of the Wnt/β-catenin pathway both in vitro and in vivo (Yang et al., 2011) , by stimulating the activity of the ALP enzyme as well as the production of ECM components including collagen type-I and osteopontin. It is conceivable that the observed response may be the result of a combination of factors rather than the sole exposure to strontium including the combination and rate of ions simultaneously released during glass degradation, which have all been described to influence cell behaviour (Maeno et al., 2005) .
Overall, the findings of this study complemented previous works, which aimed to characterise the effect of gradually substituting CaO for SrO in a PBG system. More interestingly, our group has recently reported the manufacturing of PBG microspheres in highly porous conformation with larger surface area and increased degradation rate (Hossain et al., 2018) . These microspheres have also shown the ability to encapsulate stem cells and will be further investigated for promoting cell growth and pore colonisation, to deliver enhanced advantages 
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